Kala Pharmaceuticals, Inc. (KALA)

USD 3.75

(0.81%)

Net Debt Summary of Kala Pharmaceuticals, Inc.

  • Kala Pharmaceuticals, Inc.'s latest annual net debt in 2023 was -14.57 Million USD , up 47.1% from previous year.
  • Kala Pharmaceuticals, Inc.'s latest quarterly net debt in 2024 Q2 was -17.39 Million USD , down -45.99% from previous quarter.
  • Kala Pharmaceuticals, Inc. reported annual net debt of -27.54 Million USD in 2022, down -130.54% from previous year.
  • Kala Pharmaceuticals, Inc. reported annual net debt of -11.94 Million USD in 2021, down -150.52% from previous year.
  • Kala Pharmaceuticals, Inc. reported quarterly net debt of -11.91 Million USD for 2024 Q1, up 18.23% from previous quarter.
  • Kala Pharmaceuticals, Inc. reported quarterly net debt of -15.68 Million USD for 2023 Q2, up 48.34% from previous quarter.

Annual Net Debt Chart of Kala Pharmaceuticals, Inc. (2023 - 2015)

Historical Annual Net Debt of Kala Pharmaceuticals, Inc. (2023 - 2015)

Year Net Debt Net Debt Growth
2023 -14.57 Million USD 47.1%
2022 -27.54 Million USD -130.54%
2021 -11.94 Million USD -150.52%
2020 23.65 Million USD 50.31%
2019 15.73 Million USD 122.02%
2018 -71.45 Million USD 25.5%
2017 -95.91 Million USD -167.77%
2016 -35.81 Million USD -987.46%
2015 4.03 Million USD 0.0%

Peer Net Debt Comparison of Kala Pharmaceuticals, Inc.

Name Net Debt Net Debt Difference
Esperion Therapeutics, Inc. 458.69 Million USD 103.177%
Theratechnologies Inc. 24.87 Million USD 158.59%
Safety Shot Inc -2.28 Million USD -537.899%
Cosmos Health Inc. 8.59 Million USD 269.624%
Cronos Group Inc. -663.32 Million USD 97.803%
Ironwood Pharmaceuticals, Inc. 623.38 Million USD 102.338%
Organogenesis Holdings Inc. 15.01 Million USD 197.063%
Universe Pharmaceuticals INC 197.2 Thousand USD 7489.115%
ProPhase Labs, Inc. 19.23 Million USD 175.773%
Sonoma Pharmaceuticals, Inc. -2.52 Million USD -478.254%
Dynavax Technologies Corporation 106.63 Million USD 113.665%
Radius Health, Inc. 359.28 Million USD 104.056%
China SXT Pharmaceuticals, Inc. -9.42 Million USD -54.532%
Alvotech 1.06 Billion USD 101.369%
Sunshine Biopharma, Inc. -15.63 Million USD 6.797%
Alpha Teknova, Inc. 1.97 Million USD 838.197%
Intra-Cellular Therapies, Inc. -130.82 Million USD 88.862%
SCYNEXIS, Inc. -19.35 Million USD 24.693%
Harrow Health, Inc. 116.41 Million USD 112.517%
Biofrontera Inc. 4.05 Million USD 459.27%
DURECT Corporation -7.65 Million USD -90.384%
Supernus Pharmaceuticals, Inc. -33.52 Million USD 56.537%
ANI Pharmaceuticals, Inc. 94.2 Million USD 115.468%
OptiNose, Inc. 58.06 Million USD 125.096%
RedHill Biopharma Ltd. -5.18 Million USD -180.986%
Aquestive Therapeutics, Inc. 74.95 Million USD 119.442%
Cumberland Pharmaceuticals Inc. 106.85 Thousand USD 13736.661%
SIGA Technologies, Inc. -148.68 Million USD 90.199%
Lifecore Biomedical, Inc. 121.89 Million USD 111.954%
Shineco, Inc. 29.29 Million USD 149.75%
Phibro Animal Health Corporation 454.84 Million USD 103.204%
Procaps Group S.A. 242.93 Million USD 105.998%
TherapeuticsMD, Inc. 3.67 Million USD 496.194%
Regencell Bioscience Holdings Limited -2.9 Million USD -402.235%
Viatris Inc. 17.13 Billion USD 100.085%
Sunshine Biopharma, Inc. -15.63 Million USD 6.797%
Rockwell Medical, Inc. 4.45 Million USD 427.02%
Incannex Healthcare Limited -5.48 Million USD -165.67%
Aytu BioPharma, Inc. -4.87 Million USD -198.79%
Tilray Brands, Inc. 158.97 Million USD 109.166%
Collegium Pharmaceutical, Inc. 435.33 Million USD 103.347%
PetIQ, Inc. 351.93 Million USD 104.141%
Silver Spike Investment Corp. -32.61 Million USD 55.317%
Neurocrine Biosciences, Inc. 177.3 Million USD 108.219%
Journey Medical Corporation -9.7 Million USD -50.088%
Alimera Sciences, Inc. 55.3 Million USD 126.347%
Petros Pharmaceuticals, Inc. -5.06 Million USD -187.962%
Assertio Holdings, Inc. -32.52 Million USD 55.203%
Shuttle Pharmaceuticals Holdings, Inc. -1.48 Million USD -878.826%
Embecta Corp. 1.31 Billion USD 101.111%
Cyclo Therapeutics, Inc. -8.21 Million USD -77.416%
Procaps Group, S.A. 242.93 Million USD 105.998%
PainReform Ltd. -7.95 Million USD -83.296%
Avadel Pharmaceuticals plc 4.21 Million USD 445.554%
Hempacco Co., Inc. 13.61 Million USD 207.032%
Talphera, Inc. -5.72 Million USD -154.711%
Pacira BioSciences, Inc. 432.74 Million USD 103.367%
Alvotech 1.06 Billion USD 101.369%
Lantheus Holdings, Inc. -96.71 Million USD 84.932%
Kamada Ltd. -46.43 Million USD 68.616%
Indivior PLC -33.95 Million USD 57.081%
Currenc Group, Inc. -16.57 Million USD 12.075%
Evoke Pharma, Inc. 260.57 Thousand USD 5692.269%
Flora Growth Corp. -713 Thousand USD -1943.759%
Cyclo Therapeutics, Inc. -8.21 Million USD -77.416%
Evolus, Inc. 63.7 Million USD 122.873%
HUTCHMED (China) Limited -197.45 Million USD 92.62%
Amphastar Pharmaceuticals, Inc. 479.11 Million USD 103.041%
Akanda Corp. 3.9 Million USD 473.171%